1/5/2024 0 Comments Kabe eximoIn acquiring Eximo and its laser technology, AngioDynamics enters a growing $500+ million market with an innovative medical solution that offers greater versatility, a wider range of treatments, and strong clinical data to support its efficacy.ĭifferentiated from other legacy medical devices, Eximo’s laser technology is the only system capable of delivering short, high-powered pulsed-laser energy in 355nm wavelength without compromising the integrity of its fiber optic cables during atherectomy procedures. Physicians provide atherectomy treatment to over 200,000 Americans annually 1, and Eximo’s laser technology represents a technological breakthrough among medical devices used in atherectomy procedures to treat PAD today. “The market is ripe for disruption, and the level of precision, safety, and efficiency offered to physicians by this laser technology creates a substantially differentiated alternative to legacy atherectomy devices.” “The acquisition of Eximo brings a remarkable, foundational technology to our portfolio that will change the way caregivers deliver treatment to patients with PAD,” said Jim Clemmer, President and Chief Executive Officer of AngioDynamics, Inc. The Eximo technology complements AngioDynamics’ leading thrombus management and venous insufficiency technologies. This transaction expands AngioDynamics’ existing Vascular Interventions and Therapies (VIT) product portfolio by adding Eximo’s proprietary laser technology, which has received 510(k) clearance for use in the treatment of Peripheral Artery Disease (PAD). The transaction is being funded exclusively through the use of cash on hand. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it has acquired Eximo Medical, Ltd., an early commercial stage, medical device company, and its proprietary 355nm wavelength laser-technology platform for $46 million in up-front consideration with up to $20 million of contingent consideration related to certain technical and revenue milestones. She had tan skin covered with brown fur, and dark eyes.LATHAM, N.Y.– (BUSINESS WIRE)–Oct. Kabe was a female Chadra-Fan, a species that averaged out at a height of 1 meter. Kabe used her annoying high pitched squeaks as an effective way to get the attention of Chalmun's Cantina bartender, Wuher. Shortly thereafter, Solo shot Greedo, resolving the situation to all the survivors' satisfaction. A few minutes later, she witnessed Jedi Master Obi-Wan Kenobi and Luke Skywalker fight with Dr. While waiting, she ordered a drink from Wuher at Chalmun's and shared it with Muftak. After several interrelated debts, including D'avi's plan to sell the horn to pay off Greedo, came together, Kabe found herself likely to be killed by Myo for stealing the horn if Muftak's bet with bounty hunter Djas Puhr (that Solo survive the day) didn't pan out. When confronted by an angry Myo, she implicated Muftak. She obtained the Kloo horn of Lirin D'avi from a drunken Muftak, who got it from Myo, who won it from D'avi's son Lirin Car'n, and pawned it to repay the debt Myo owed her and Muftak. In 0 BBY, Kabe was living with Muftak in the maintenance tunnels under Chalmun's, paying rent to Ackmena with proceeds obtained by petty theft and scams. Kabe then bought Blue milk from Wuher with those credits. Kabe eventually captured the item and gave it to the man which he gave her credits. Kabe then heard a man and an alien talking about a imperial cruiser loaded with a valuable item aboard. Kabe overhears talking about a valuable item.Īt some point at Chalmun's Cantina, Kabe tried to order Blue milk from Wuher, but had zero credits. " Cute faces ain't a form of currency, Kabe." ―Wuher to Kabe Ī female Chadra-Fan who was a patron of Chalmun's Spaceport Cantina.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |